Found 65 matching trials
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients PHASE2 The goal of this clinical research study is to learn if temozolomide alone ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg PHASE4 HBeAg-negative chronic hepatitis B (CHB) patients with low Level HBsAg and ...
Show More Location
Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 This phase I trial is studying the side effects of decitabine when given to...
Show More Location
Nevada Cancer Institute-Summerlin Campus
Learn More & Join Trial
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL NA RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Show More Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Learn More & Join Trial
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 PHASE4 This sudy will determine whether shortening treatment for hepatitis C is fe...
Show More Location
Hunter Pharmacotherapy
Learn More & Join Trial
To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. NA The study is to guide clinical cure of peginterferon alfa-2a treatment in p...
Show More Learn More & Join Trial
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) PHASE3 This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) PHASE4 This is an Australian, open-label, multicenter, randomized, double-blind cl...
Show More Location
Multiple Locations
Learn More & Join Trial